Ann-Christin Eder

Cytoplasmic Localization of Prostate-Specific Membrane Antigen Inhibitors May Confer Advantages for Targeted Cancer Therapies

Jessica Matthias, Johann Engelhardt, Martin Schäfer et al. · Cancer Research · 2021 · 31 citations · Full text

Medicine, Cell Biology, Oncology +17

Prognostic Value of Tumor Volume Assessment on PSMA PET After¹⁷⁷Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0

Felix Kind, Ann-Christin Eder, Cordula A. Jilg et al. · Journal of Nuclear Medicine · 2022 · 31 citations · Full text

Medicine, Oncology, Radiology +17

Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer

Mohamed El Fakiri, Nawal Ayada, Marius Müller et al. · Journal of Nuclear Medicine · 2024 · 24 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

Development and preclinical characterization of a novel radiotheranostic EphA2-targeting bicyclic peptide

Mohamed El Fakiri, Anusha Regupathy, Lisa Uhlmann et al. · Theranostics · 2024 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [¹⁷⁷Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside

D. Arbuznikova, A. Klotsotyra, Lisa Uhlmann et al. · Theranostics · 2024 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17